Provided are compounds that are useful in the treatment and/or prevention of diseases mediated by deficient levels of glucokinase activity, such as diabetes mellitus. Also provided are methods of treating or preventing diseases and disorders characterized by underactivity of glucokinase or which can be treated by activating glucokinase.
提供的化合物可用于治疗和/或预防由
胰岛素受体激酶活性不足引起的疾病,如糖尿病。还提供了治疗或预防
胰岛素受体激酶活性不足或可通过激活
胰岛素受体激酶治疗的疾病和疾病的方法。